Cell and gene therapies (CGTs) are reshaping medicine. Hundreds of clinical trials are underway worldwide, and the first wave of commercial therapies is already changing the outlook for patients with rare diseases and cancers. Yet as the industry races toward commercialization, a fundamental challenge is threatening to slow progress: preserving the integrity of living cells from the lab to the patient.
One of the most underappreciated risks in this journey are transient warming events (TWE)
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
MRO Acquires Clinetic to Accelerate Clinical Trial Patient Recruitment with AI-Driven Data
What You Should Know:
- MRO has acquired Clinetic, a recruitment management platform, to enhance its smarter data commitment. Financial details of the acquisition were not disclosed.
- The acquisition integrates Clinetic’s AI-driven software, which leverages real-time EHR data to identify, screen, and enroll clinical trial patients faster and with greater precision.
MRO Strengthens "Smarter Data" Focus with Clinetic Acquisition
MRO, a company committed to being the single
Read More
Function Launches Medical Intelligence Lab to Decode Longevity with AI and 100+ Biomarkers
What You Should Know:
- Function has created a new category in preventive health—one that shifts how people think about longevity, early detection, and everyday decision-making. The company’s mission is simple but ambitious: empower people to live 100 healthy years. It began by redefining routine testing through its bi-annual, 100+ biomarker lab panel, giving individuals an expansive, longitudinal view of their changing biology.
- The acquisition of Ezra accelerated
Read More
Pharma × AI: The End of Pilots and the Rise of Captive AI Boutiques
What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory bench? The answer is arriving faster than many realize.
For years, the relationship between artificial intelligence (AI) startups and big pharma followed a familiar script: a splashy press release, a limited pilot, and then silence after millions were spent in R&D. AI companies gained validation; pharma
Read More
From Chatbots to Agents: How GPT-5 is Reshaping Healthcare and Pharma
Pharma is embracing GPT-5, shifting AI from chatbot to enterprise agent as it accelerates productivity amid regulatory challenges.
Large pharmaceutical and biotech companies have spent the last couple of years running specific pilots involving artificial intelligence (AI). Learnings from these forays have formed a basis for AI readiness and a guide for industry to weave generative AI into enterprise strategies. Even regulators have been experimenting with AI to offset staff shortages and
Read More
Cellbyte Raises $2.75M to Accelerate Drug Launches with AI-Native Platform
What You Should Know:
- Cellbyte, the AI-native platform that helps pharmaceutical companies accelerate drug launches, announces that it has raised $2.75 million in seed funding.
- The round was led by Frontline Ventures, with participation from Y Combinator, Pace Ventures, Saras Capital and Springboard Health Angels.
Cellbyte: Rebuilding Global Drug Launch Workflows for the AI Era
Cellbyte is an AI-native platform transforming how pharmaceutical companies prepare, price, and launch
Read More
Barbados to Establish $200M Life Sciences Hub for the Caribbean
What You Should Know:
- Export Barbados (BIDC) and the Dubai-headquartered EarlyHealth Group (EHG), a global pharmaceutical services and life sciences company, have signed a Letter of Intent to jointly establish EarlyHealth City Barbados.
- The $200M world-class pharmaceutical and life sciences cluster aims to attract international pharmaceutical partners, drive industrialisation through sustainable contract manufacturing, and expand laboratory and clinical research capacity in
Read More
myTomorrows Secures $29M to Fuel Global Expansion of Pre-Approval Therapy Access
What You Should Know:
- myTomorrows, a health technology company that connects patients with all possible pre-approval treatments, today announced the close of a $29 million financing with Avego. Avego’s growth equity investment will fuel the global expansion of myTomorrows’ integrated pharma solutions to make emerging treatments more equitable and accessible for patients globally.
- With more than 300 million patients worldwide facing conditions without approved treatment options, and
Read More
Onchilles Pharma Raises $25M to Advance N17350, Pioneering Next-Gen Cytotoxic Cancer Therapy
What You Should Know:
- Onchilles Pharma, a private biotech company pioneering next-generation cytotoxic therapeutics announced the publication of foundational preclinical data in the peer-reviewed journal Cell Reports Medicine, the close of a $25M Series A1 financing round.
- In addition, the company appointed Dr. Thomas A. Buchholz as a clinical advisor. The funding brings the total raised in Series A financing to $40M.
Foundational Preclinical Data Validates Cancer-Selective
Read More
The Agentic Workforce: 10 New AI Roles Transforming Life Sciences Operations by 2032
As AI agents move from concept to colleague, the life sciences workforce is about to expand – no desks required.
While much of the activity is still in testing phases, AI agents are already making a difference in specific, high-return areas. AI is being used for processing and sorting pharmacovigilance (PV) reports, drafting medical and regulatory documents, assisting with lab operations, inspecting product quality, and helping employees find internal information.
The coming year will see
Read More
